Fig. 4. Effect of Drome-DH44 on cyclic nucleotide levels. (A)
Drome-DH44 elevates intracellular cAMP levels. Intracellular cAMP
levels in wild-type (Oregon R) tubules were measured under control and
Drome-DH44 stimulated conditions by radioimmunoassay. The results
are expressed as percentage increase of basal rate on peptide stimulation
(stimulated ratemean basal rate)x100/mean basal rate). Values are
means ± S.E.M. (N=5-9;): stimulation of cAMP is significant
(P<0.05) for concentrations above 10-8
moll-1. The mean basal cAMP level was 383±43 fmol/20
tubules. (B) cGMP levels are not affected by Drome-DH44.
Intracellular levels of cyclic GMP did not show a significant difference
between control and Drome-DH44 (10-7 moll-1)
stimulated conditions by RIA. The results are expressed as means ±
S.E.M., N=4 independent samples, each pooled from 20 tubules. (C,D)
Drome-DH44-induced increase in cAMP is confined to principal cells.
Immunocytochemistry of whole-mount tubules in control cells (C) and 10 min
after application of 10-7 moll-1 Drome-DH44
(D). Images were recorded under identical filter and exposure settings, using
a matched-pair protocol. A typical stellate cell is outlined in each
photograph.